Lawsuit Alleges Trump Administration Shared Asylum Data with Iran
A new federal lawsuit alleges that U.S. immigration agencies shared confidential information about Iranian asylum see...
Articles — Page 299
FDA Urges Immediate Stop on Nara Organics Infant Formula
The FDA has issued an urgent advisory to stop feeding infants Nara Organics infant formula after botulism cases were ...
Says Victoria Beckham Nearly: A Finance Lesson Spice Row
A moment of misread cues, a tense room, and suddenly a career trajectory could pivot from spotlight to setback. This ...
Adele’s Rare Return Sparks Financial Spotlight and Insight
Public moments can shift finances as quickly as headlines change. This article uses adele’s rare return sparks as a s...
Meta Platforms About Follow: Will It Echo SpaceX's Playbook?
Could Meta Platforms About Follow the SpaceX playbook and turn idle AI compute into a new revenue stream? This articl...
Should Tesla Stock Before July 22? A Practical Guide
As July 22 approaches, investors face a familiar crossroads: take a position before earnings or wait for the full pic...
Could Roivant Sciences Be a Multibagger Stock Soon
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
If I Could Tell Investors Thing About the SpaceX IPO
SpaceX's IPO headlines would be enormous and tempting. This article shares the one clear message I’d tell every inves...
QQQ: Which Index Fund Is Best for Long-Term Investors
Two powerhouse index funds—VOO and QQQ—pose a classic choice for long-term investors. This guide breaks down growth p...
Meta Platforms Just Gave a Massive Warning to AI Infra
Meta Platforms Just Gave A Massive Warning To AI Infra. As Meta pivots toward renting excess cloud capacity, small ne...
Why Nu Stock Plunged First Half: Key Drivers Explained
Nu Holdings faced a 20% stock drop in the first half of the year. This piece breaks down the mix of competition, macr...
Forget Anthropic IPO: These Stocks Could Benefit First
Anthropic’s IPO path is shaping AI headlines, but patient investors can still win by focusing on established tech gia...